CA41465-7A - 0x0000000000006440
Males & Females of Non-Childbearing Potential
Ginger
* Stipend may pay up to reflected amount.
Start Date:
May 3, 2025 - 11:00am
End Date:
June 2, 2025 - 10:15am
Study Details
Study Number: CA41465
Group Number: 7A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,000.00
Study Criteria
Age: 18 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat nausea and vomiting.
Route of Administration: Injection subcutaneous
Blood Draws: 23
Study Schedule
Schedule Type: Short stays with returns
Study Length: 6 Night Stay & 3 Returns
Screening Dates:
| Event Day | Event Date |
|---|---|
| Wednesday | 4/30/2025 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Wednesday | 4/30/2025 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Saturday | 5/3/2025 11:00:00 AM | Friday | 5/9/2025 10:30:00 AM | 1 | Phoenix |
| Return | Monday | 5/12/2025 9:15:00 AM | Monday | 5/12/2025 10:15:00 AM | 1 | Phoenix |
| Return | Sunday | 5/18/2025 9:15:00 AM | Sunday | 5/18/2025 10:15:00 AM | 1 | Phoenix |
| Return | Monday | 6/2/2025 9:15:00 AM | Monday | 6/2/2025 10:15:00 AM | 1 | Phoenix |
